Fund shareholders of ADMA Biologics Inc
ISIN US0008991046 · United States
- Fund shareholders
- 317
- Of which ETFs
- 82 235 other funds
- Value held
- 1.1B $ 936.4K € · 6.7M SEK
- Share of capital
- 47.3 % of 224M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| SMALL-CAP PROFUND ProFunds | 423 | 4.3K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 410 | 6.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 317 | 2.9K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam VT Global Asset Allocation Fund Putnam Variable Trust | 304 | 2.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 238 | 3.7K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 229 | 2.1K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 150 | 2.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Founders 100 ETF Founder Funds Trust | 134 | 1.2K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 130 | 1.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 130 | 1.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 110 | 1.7K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 74 | 1.2K $ | 0.10 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 61 | 549.6 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ACIMUT NORTH AMERICAN MANAGERS, FI MUTUACTIVOS, S.A., S.G.I.I.C. | 674.8K € | 0.71 % | as of Dec 31, 2025 ↗ | ||
| GVC GAESCO ZEBRA US SMALL CAPS LOW POPULARITY, FI GVC GAESCO GESTIÓN, SGIIC, S.A. | 123.8K € | 0.95 % | as of Dec 31, 2025 ↗ | ||
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 77.6K € | 0.58 % | as of Dec 31, 2025 ↗ | ||
| DIRECTOR GROWTH, FI INVERSIS GESTIÓN, S.A., SGIIC | 60.2K € | 1.81 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Motley Fool Small-Cap Growth ETF RBB Fund, Inc. | 2.42 % | as of Feb 28, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 2.21 % | as of Feb 28, 2026 ↗ |
| DIRECTOR GROWTH, FI INVERSIS GESTIÓN, S.A., SGIIC | 1.81 % | as of Dec 31, 2025 ↗ |
| Transamerica Small Cap Growth TRANSAMERICA FUNDS | 1.52 % | as of Apr 30, 2026 ↗ |
| Ranger Small Cap Fund SPEND LIFE WISELY FUNDS INVESTMENT TRUST | 1.51 % | as of Apr 30, 2026 ↗ |
| Ranger Micro Cap Fund SPEND LIFE WISELY FUNDS INVESTMENT TRUST | 1.47 % | as of Apr 30, 2026 ↗ |
| Nationwide Renaissance Small Cap Growth Fund Nationwide Mutual Funds | 1.42 % | as of Apr 30, 2026 ↗ |
| MetLife Small Company Equity Fund ADVISORS' INNER CIRCLE III | 1.30 % | as of Mar 31, 2026 ↗ |
| Invesco S&P SmallCap 600 GARP ETF Invesco Exchange-Traded Fund Trust II | 1.29 % | as of Feb 28, 2026 ↗ |
| Invesco S&P SmallCap Quality ETF Invesco Exchange-Traded Fund Trust II | 0.99 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 312 | -57 | 105,823,420 | -6.7 % |
| 2026Q1 | 369 | -5 | 113,475,257 | +2.8 % |
| 2025Q4 | 374 | -48 | 110,430,499 | -4.1 % |
| 2025Q3 | 422 | +29 | 115,159,487 | +9.3 % |
| 2025Q2 | 393 | +30 | 105,384,769 | +3.1 % |
| 2025Q1 | 363 | +46 | 102,228,221 | +2.7 % |
| 2024Q4 | 317 | +82 | 99,578,399 | +34.8 % |
| 2024Q3 | 235 | +39 | 73,894,257 | +15.0 % |
| 2024Q2 | 196 | +13 | 64,235,930 | +4.2 % |
| 2024Q1 | 183 | +4 | 61,641,342 | +6.9 % |
| 2023Q4 | 179 | 57,680,983 |
Institutional managers
348 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 36,830,774 | 331.8M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 14,084,205 | 126.9M $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 11,191,116 | 100.8M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 6,098,225 | 54.9M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 5,824,116 | 52.5M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 5,810,642 | 52.4M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 5,005,481 | 45.1M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 4,789,011 | 43.1M $ | as of Mar 31, 2026 |
| Caligan Partners LP | 4,756,511 | 42.9M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 4,119,577 | 37.1M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 3,997,675 | 36M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,434,449 | 30.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 3,288,757 | 29.6M $ | as of Mar 31, 2026 |
| B Group, Inc. | 3,207,542 | 28.9M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 3,051,943 | 27.5M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 2,803,530 | 25.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,434,379 | 21.9M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,344,899 | 21.1M $ | as of Mar 31, 2026 |
| Ranger Investment Management, L.P. | 2,283,810 | 20.6M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,277,312 | 20.5M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,216,285 | 20K $ | as of Mar 31, 2026 |
| UBS Group AG | 2,150,276 | 19.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,095,772 | 18.9M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 2,092,133 | 18.9M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 1,905,472 | 17.2M $ | as of Mar 31, 2026 |
Declared shareholders of ADMA Biologics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 5.08 % | 12,110,153 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of ADMA Biologics Inc". https://titelia.com/en/stocks/adma-biologics-inc-US0008991046